The aim of this study is to assess that the sleeve gastrectomy can improve the risk benefit than the gastric bypass
In the obese patient population, the frequency of patients presenting a severe morbid obesity (40 \>= BMI \<= 50), a super obesity (BMI \>50), a super super obesity (BMI\>60), and obese patients (BMI\>35) with a failure of gastric banding is constantly increasing. In these patients, the surgery risk is proportionate to the weight and / or gastric surgery records. This risk is high, in bariatric surgery, for gastric bypass procedure. This justifies the evaluation of new procedure to reduce the morbidity allowing the reduction of morbid /mortality associated with the intervention.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
280
Laparoscopic sleeve gastrectomy is a restrictive procedure for the treatment for morbid obesity
Laparoscopic gastric bypass is a restrictive and difficult absorption procedure for the treatment of morbid obesity
Service de chirurgie digestive / Centre Hospitalier Général de Saint-Denis Delafontaine
Saint-Denis, France
Composite criteria of morbid/mortality
Time frame: during 18 months and 36 months
Frequency of morbid events
Time frame: during the follow up
Percentage of excess weight loss
Time frame: during 18 and 36 months
Frequency of patients having a excess weight loss superior than 50%
Time frame: during 36 months
Regression of morbidities
Time frame: during 36 months
Rate serum ghrelin
Time frame: at inclusion visit, 6, 12, 18 and 36 months
Evaluation of quality of life and scores of precariousness, SF 36, EPWORTH Score, Lequesne' Score, Insecure' Score
Time frame: at inclusion visit, 6, 12, 18 and 36 months
Frequency of morbid/mortality events
Time frame: during 36 months
Frequency of patients having excess weight loss superior than 50%
Time frame: during 18 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.